Adenovirus type 4 a

Ended Awarded

Contract number
SPE2DP20F2430
Awardee
Awarding agency
Obligated
$1,221,723

Award facts

Opportunity
Contract value 100% obligated
$1,221,723.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
North Wales, PA 19454, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Teva Pharmaceuticals USA, Inc. was awarded a $1.2 million firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4 to the agency. The contract has a period of performance from February 7 to February 11, 2020, with all work to be conducted by Teva at its facility located in North Wales, Pennsylvania. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA medical product contract vehicle and will supply the agency with the requested adenovirus type 4 to support its troop health programs during the specified timeframe.

Quick answers

Who was awarded contract SPE2DP20F2430?

SPE2DP20F2430 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on February 7, 2020.

How much is contract SPE2DP20F2430 worth?

The government has obligated $1,221,723 on SPE2DP20F2430.

Is contract SPE2DP20F2430 an order under another contract?

Yes. SPE2DP20F2430 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP20F2430 competed?

The extent of competition for SPE2DP20F2430 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login